Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, announced recently on the 13th of June that it had acquired Remote Diagnostic Technologies, a UK-based leading innovator of advanced solutions for the pre-hospital market. This represents an important financial exit for ESA Business Applications investment in RDT.
RDT’s portfolio of emergency care solutions powered by Space such as the Tempus Pro (above, in use during the return to Earth of ESA astronaut Thomas Pesquet) will complement Philips’ Therapeutic Care business and strengthen its leadership position in the EUR 1.4 billion resuscitation and emergency care market.
“We are committed to investing in and expanding our resuscitation and emergency care offering, and with the acquisition of RDT we can boost our capabilities and portfolio in this vital area of healthcare," said Arman Voskerchyan, Business Leader for Therapeutic Care at Philips. "With its focus on the prehospital market, RDT’s portfolio of emergency care solutions will enable Philips to grow its presence in this market, as we further build our health technology portfolio and extend the range of connected, data-driven solutions we offer to our customers.”
“We are delighted to become part of Philips and continue on our journey that began over 20 years ago”, said Graham Murphy, CEO of RDT. “Our mission is very much aligned with Philips’ own, as we are committed to transforming the delivery of care and improving patient outcomes driven by customer-focused innovation. Together, we will continue to enable prehospital caregivers to make a real difference to patient outcomes everywhere.”